These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25697583)

  • 1. Fasudil prevents calcium oxalate crystal deposit and renal fibrogenesis in glyoxylate-induced nephrolithic mice.
    Hu H; Chen W; Ding J; Jia M; Yin J; Guo Z
    Exp Mol Pathol; 2015 Apr; 98(2):277-85. PubMed ID: 25697583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of fasudil on renal interstitial fibrosis induced by unilateral ureteral obstruction.
    Baba I; Egi Y; Utsumi H; Kakimoto T; Suzuki K
    Mol Med Rep; 2015 Dec; 12(6):8010-20. PubMed ID: 26498136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitexin exerts protective effects against calcium oxalate crystal-induced kidney pyroptosis in vivo and in vitro.
    Ding T; Zhao T; Li Y; Liu Z; Ding J; Ji B; Wang Y; Guo Z
    Phytomedicine; 2021 Jun; 86():153562. PubMed ID: 33857849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhalation of hydrogen gas ameliorates glyoxylate-induced calcium oxalate deposition and renal oxidative stress in mice.
    Peng Z; Chen W; Wang L; Ye Z; Gao S; Sun X; Guo Z
    Int J Clin Exp Pathol; 2015; 8(3):2680-9. PubMed ID: 26045773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment with fasudil improves bleomycin-induced pulmonary fibrosis and pulmonary hypertension via inhibition of Smad2/3 phosphorylation.
    Bei Y; Hua-Huy T; Duong-Quy S; Nguyen VH; Chen W; Nicco C; Batteux F; Dinh-Xuan AT
    Pulm Pharmacol Ther; 2013 Dec; 26(6):635-43. PubMed ID: 23928001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of fasudil on the epithelial-mesenchymal transdifferentiation of renal tubular epithelial cells from diabetic rats.
    Wu G; Tu Y; Jia R
    Biomed Pharmacother; 2010 Feb; 64(2):124-9. PubMed ID: 20006464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RhoA/Rho-kinase activation promotes lung fibrosis in an animal model of systemic sclerosis.
    Bei Y; Hua-Huy T; Nicco C; Duong-Quy S; Le-Dong NN; Tiev KP; Chéreau C; Batteux F; Dinh-Xuan AT
    Exp Lung Res; 2016; 42(1):44-55. PubMed ID: 26873329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho kinase inhibition by fasudil attenuates cyclosporine-induced kidney injury.
    Park JW; Park CH; Kim IJ; Bae EH; Ma SK; Lee JU; Kim SW
    J Pharmacol Exp Ther; 2011 Jul; 338(1):271-9. PubMed ID: 21474569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful formation of calcium oxalate crystal deposition in mouse kidney by intraabdominal glyoxylate injection.
    Okada A; Nomura S; Higashibata Y; Hirose M; Gao B; Yoshimura M; Itoh Y; Yasui T; Tozawa K; Kohri K
    Urol Res; 2007 Apr; 35(2):89-99. PubMed ID: 17393196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alleviation of the doxorubicin-induced nephrotoxicity by fasudil in vivo and in vitro.
    Xiang C; Yan Y; Zhang D
    J Pharmacol Sci; 2021 Jan; 145(1):6-15. PubMed ID: 33357780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment of Rho kinase inhibitor inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in mice.
    Ding RY; Zhao DM; Zhang ZD; Guo RX; Ma XC
    J Surg Res; 2011 Dec; 171(2):e209-14. PubMed ID: 21962807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho-Kinase inhibitor fasudil suppresses high glucose-induced H9c2 cell apoptosis through activation of autophagy.
    Gao H; Hou F; Dong R; Wang Z; Zhao C; Tang W; Wu Y
    Cardiovasc Ther; 2016 Oct; 34(5):352-9. PubMed ID: 27333569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasudil, a Rho‑kinase inhibitor, prevents intima‑media thickening in a partially ligated carotid artery mouse model: Effects of fasudil in flow‑induced vascular remodeling.
    Zhang X; Zhang T; Gao F; Li Q; Shen C; Li Y; Li W; Zhang X
    Mol Med Rep; 2015 Nov; 12(5):7317-25. PubMed ID: 26458725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
    Chen XY; Dun JN; Miao QF; Zhang YJ
    Pharmacology; 2009; 83(2):67-79. PubMed ID: 19052484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasudil, a Rho kinase inhibitor, drives mobilization of adult neural stem cells after hypoxia/reoxygenation injury in mice.
    Ding J; Li QY; Yu JZ; Wang X; Sun CH; Lu CZ; Xiao BG
    Mol Cell Neurosci; 2010 Feb; 43(2):201-8. PubMed ID: 19913617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo.
    Deng L; Li G; Li R; Liu Q; He Q; Zhang J
    Cancer Biol Ther; 2010 Jun; 9(11):875-84. PubMed ID: 20364104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of fasudil, a Rho-kinase inhibitor, on chemokine expression, leukocyte recruitment, and hepatocellular apoptosis in septic liver injury.
    Thorlacius K; Slotta JE; Laschke MW; Wang Y; Menger MD; Jeppsson B; Thorlacius H
    J Leukoc Biol; 2006 May; 79(5):923-31. PubMed ID: 16641138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses high glucose-induced proliferation and collagen synthesis in rat cardiac fibroblasts.
    Zhou H; Zhang KX; Li YJ; Guo BY; Wang M; Wang M
    Clin Exp Pharmacol Physiol; 2011 Jun; 38(6):387-94. PubMed ID: 21457293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasudil, an inhibitor of Rho-associated coiled-coil kinase, improves cognitive impairments induced by smoke exposure.
    Xueyang D; Zhanqiang M; Chunhua M; Kun H
    Oncotarget; 2016 Nov; 7(48):78764-78772. PubMed ID: 27791202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasudil attenuates lipopolysaccharide-induced acute lung injury in mice through the Rho/Rho kinase pathway.
    Li Y; Wu Y; Wang Z; Zhang XH; Wu WK
    Med Sci Monit; 2010 Apr; 16(4):BR112-118. PubMed ID: 20357711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.